287 related articles for article (PubMed ID: 16798111)
21. Diagnosis of eight groups of xeroderma pigmentosum by genetic complementation using recombinant adenovirus vectors.
Yamashita T; Okura M; Ishii-Osai Y; Hida T
J Dermatol; 2016 Oct; 43(10):1167-1173. PubMed ID: 26971583
[TBL] [Abstract][Full Text] [Related]
22. Complementation of defective translesion synthesis and UV light sensitivity in xeroderma pigmentosum variant cells by human and mouse DNA polymerase eta.
Yamada A; Masutani C; Iwai S; Hanaoka F
Nucleic Acids Res; 2000 Jul; 28(13):2473-80. PubMed ID: 10871396
[TBL] [Abstract][Full Text] [Related]
23. Replication of damaged DNA: molecular defect in xeroderma pigmentosum variant cells.
Cordonnier AM; Fuchs RP
Mutat Res; 1999 Oct; 435(2):111-9. PubMed ID: 10556591
[TBL] [Abstract][Full Text] [Related]
24. Association between DNA repair-deficiency and high level of p53 mutations in melanoma of Xeroderma pigmentosum.
Spatz A; Giglia-Mari G; Benhamou S; Sarasin A
Cancer Res; 2001 Mar; 61(6):2480-6. PubMed ID: 11289118
[TBL] [Abstract][Full Text] [Related]
25. Molecular genetics of Xeroderma pigmentosum variant.
Gratchev A; Strein P; Utikal J; Sergij G
Exp Dermatol; 2003 Oct; 12(5):529-36. PubMed ID: 14705792
[TBL] [Abstract][Full Text] [Related]
26. Common pathways for ultraviolet skin carcinogenesis in the repair and replication defective groups of xeroderma pigmentosum.
Cleaver JE
J Dermatol Sci; 2000 May; 23(1):1-11. PubMed ID: 10699759
[TBL] [Abstract][Full Text] [Related]
27. Selective DNA damage responses in murine Xpa-/-, Xpc-/- and Csb-/- keratinocyte cultures.
Stout GJ; Oosten Mv; Acherrat FZ; Wit Jd; Vermeij WP; Mullenders LH; Gruijl FR; Backendorf C
DNA Repair (Amst); 2005 Nov; 4(11):1337-44. PubMed ID: 16182614
[TBL] [Abstract][Full Text] [Related]
28. CPD-photolyase adenovirus-mediated gene transfer in normal and DNA-repair-deficient human cells.
Chiganças V; Sarasin A; Menck CF
J Cell Sci; 2004 Jul; 117(Pt 16):3579-92. PubMed ID: 15252127
[TBL] [Abstract][Full Text] [Related]
29. Decreased frequency and highly aberrant spectrum of ultraviolet-induced mutations in the hprt gene of mouse fibroblasts expressing antisense RNA to DNA polymerase zeta.
Diaz M; Watson NB; Turkington G; Verkoczy LK; Klinman NR; McGregor WG
Mol Cancer Res; 2003 Sep; 1(11):836-47. PubMed ID: 14517346
[TBL] [Abstract][Full Text] [Related]
30. Functional lentiviral vectors for xeroderma pigmentosum gene therapy.
Marchetto MC; Correa RG; Menck CF; Muotri AR
J Biotechnol; 2006 Dec; 126(4):424-30. PubMed ID: 16857285
[TBL] [Abstract][Full Text] [Related]
31. Increased susceptibility to UV-induced skin carcinogenesis in polymerase eta-deficient mice.
Lin Q; Clark AB; McCulloch SD; Yuan T; Bronson RT; Kunkel TA; Kucherlapati R
Cancer Res; 2006 Jan; 66(1):87-94. PubMed ID: 16397220
[TBL] [Abstract][Full Text] [Related]
32. Xeroderma pigmentosum variant: complementary molecular approaches to detect a 13 base pair deletion in the DNA polymerase eta gene.
Hentosh P; Benjamin T; Hall L; Leap S; Loescher J; Poyner E; Sundin T; Whittle M; Wilkinson S; Peffley DM
Exp Mol Pathol; 2011 Oct; 91(2):528-33. PubMed ID: 21640722
[TBL] [Abstract][Full Text] [Related]
33. Cell-type-specific consequences of nucleotide excision repair deficiencies: Embryonic stem cells versus fibroblasts.
de Waard H; Sonneveld E; de Wit J; Esveldt-van Lange R; Hoeijmakers JH; Vrieling H; van der Horst GT
DNA Repair (Amst); 2008 Oct; 7(10):1659-69. PubMed ID: 18634906
[TBL] [Abstract][Full Text] [Related]
34. DNA polymerase eta, the product of the xeroderma pigmentosum variant gene and a target of p53, modulates the DNA damage checkpoint and p53 activation.
Liu G; Chen X
Mol Cell Biol; 2006 Feb; 26(4):1398-413. PubMed ID: 16449651
[TBL] [Abstract][Full Text] [Related]
35. Role of postreplication repair in transformation of human fibroblasts to anchorage independence.
Boyer JC; Kaufmann WK; Cordeiro-Stone M
Cancer Res; 1991 Jun; 51(11):2960-4. PubMed ID: 1903328
[TBL] [Abstract][Full Text] [Related]
36. The human POLH gene is not mutated, and is expressed in a cohort of patients with basal or squamous cell carcinoma of the skin.
Flanagan AM; Rafferty G; O'Neill A; Rynne L; Kelly J; McCann J; Carty MP
Int J Mol Med; 2007 Apr; 19(4):589-96. PubMed ID: 17334634
[TBL] [Abstract][Full Text] [Related]
37. Recapitulation of the cellular xeroderma pigmentosum-variant phenotypes using short interfering RNA for DNA polymerase H.
Laposa RR; Feeney L; Cleaver JE
Cancer Res; 2003 Jul; 63(14):3909-12. PubMed ID: 12873983
[TBL] [Abstract][Full Text] [Related]
38. Genomic structure, chromosomal localization and identification of mutations in the xeroderma pigmentosum variant (XPV) gene.
Yuasa M; Masutani C; Eki T; Hanaoka F
Oncogene; 2000 Sep; 19(41):4721-8. PubMed ID: 11032022
[TBL] [Abstract][Full Text] [Related]
39. Translesion replication in cisplatin-treated xeroderma pigmentosum variant cells is also caffeine-sensitive: features of the error-prone DNA polymerase(s) involved in UV-mutagenesis.
Yamada K; Takezawa J; Ezaki O
DNA Repair (Amst); 2003 Aug; 2(8):909-24. PubMed ID: 12893087
[TBL] [Abstract][Full Text] [Related]
40. Correlation of phenotype/genotype in a cohort of 23 xeroderma pigmentosum-variant patients reveals 12 new disease-causing POLH mutations.
Opletalova K; Bourillon A; Yang W; Pouvelle C; Armier J; Despras E; Ludovic M; Mateus C; Robert C; Kannouche P; Soufir N; Sarasin A
Hum Mutat; 2014 Jan; 35(1):117-28. PubMed ID: 24130121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
